Fan Emily Yang

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

Kristian Reich, Kenji Kabashima, Ketty Peris et al. · JAMA Dermatology · 2020 · 279 citations · Full text

Medicine, Dermatology, Pharmacology +15

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

Caitriona Ryan, Alan Menter, Lyn Guenther et al. · British Journal of Dermatology · 2018 · 119 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)

Thomas Bieber, Kristian Reich, C. Paul et al. · British Journal of Dermatology · 2022 · 76 citations · Full text

Medicine, Dermatology, Pharmacology +16

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis

April W. Armstrong, Charles Lynde, Sandy McBride et al. · JAMA Dermatology · 2016 · 53 citations

Medicine, Dermatology, Pharmacotherapy +9

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial

Andreas Wollenberg, Takeshi Nakahara, Catherine Maari et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 53 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13